Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | PLAU | P00749 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16070594 | 1.00 | TSHR (0.38) | TSHRCYP3A4HDAC8TAAR1HIF1A | |
| SCHEMBL16070578 | 1.00 | TSHR (0.38) | TSHRCYP3A4HDAC8TAAR1HIF1A | |
| SCHEMBL16070643 | 0.83 | HDAC8 (0.34) | TSHRHDAC8TAAR1HIF1AHTR3A | |
| SCHEMBL16070657 | 0.83 | HDAC8 (0.34) | TSHRHDAC8TAAR1HIF1AHTR3A | |
| SCHEMBL16070651 | 0.83 | HDAC8 (0.34) | TSHRHDAC8TAAR1HIF1AHTR3A | |
| SCHEMBL16070593 | 0.82 | HDAC8 (0.33) | TSHRHDAC8TAAR1HIF1AHTR3A | |
| SCHEMBL16070608 | 0.82 | HDAC8 (0.33) | TSHRHDAC8TAAR1HIF1AHTR3A | |
| SCHEMBL17518200 | 0.81 | LMNA (0.54) | TSHRCYP3A4HDAC8TAAR1HIF1A | |
| SCHEMBL13849426 | 0.81 | LMNA (0.54) | TSHRCYP3A4HDAC8TAAR1HIF1A | |
| SCHEMBL17438169 | 0.81 | TSHR (0.48) | TSHRCYP3A4TAAR1HIF1AHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200308105-A1 | NOVEL METHOD FOR PRODUCING HYDROXAMIC ACID DERIVATIVE, AND INTERMEDIATE THEREFOR | FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20200308105-A1 | NOVEL METHOD FOR PRODUCING HYDROXAMIC ACID DERIVATIVE, AND INTERMEDIATE THEREFOR | FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20200308103-A1 | NOVEL CRYSTALS OF HYDROXAMIC ACID DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION | TOYAMA CHEMICAL CO., LTD. (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20200308103-A1 | NOVEL CRYSTALS OF HYDROXAMIC ACID DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION | TOYAMA CHEMICAL CO., LTD. (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20200062789-A1 | HYDROXAMIC ACID PRODRUG COMPOUND OR SALT THEREOF, LYOPHILIZED FORMULATION, LPXC INHIBITOR, AND ANTIBACTERIAL AGENT | FUJIFILM TOYAMA CHEMICAL CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| EP-3192503-B1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | FUJIFILM TOYAMA CHEMICAL CO LTD (JP) | 2019-08-14 | — | — | EP | disclosed |
| EP-2975022-B1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | FUJIFILM TOYAMA CHEMICAL CO LTD (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-20190054179-A1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2019-02-21 | — | — | US | disclosed |
| US-20190054179-A1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2019-02-21 | — | — | US | disclosed |
| EP-3438088-A1 | CRYSTALS OF NOVEL HYDROXAMIC ACID DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION | Toyama Chemical Co., Ltd. (JP) | 2019-02-06 | — | — | EP | disclosed |
| EP-3192503-A1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-3192505-A1 | METHOD FOR USING NOVEL HYDROXAMIC ACID DERIVATIVE AND ANTIBACTERIAL SUBSTANCE IN COMBINATION | TOYAMA CHEMICAL CO., LTD. (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-3192505-A1 | METHOD FOR USING NOVEL HYDROXAMIC ACID DERIVATIVE AND ANTIBACTERIAL SUBSTANCE IN COMBINATION | TOYAMA CHEMICAL CO., LTD. (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-3192503-A1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2017-07-19 | — | — | EP | disclosed |
| US-20160039751-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2016-02-11 | — | — | US | disclosed |
| US-20160039751-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2016-02-11 | — | — | US | disclosed |
| US-20160039751-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2016-02-11 | — | — | US | disclosed |
| EP-2975022-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | Toyama Chemical Co., Ltd. (JP) | 2016-01-20 | — | — | EP | disclosed |
| EP-2975022-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | Toyama Chemical Co., Ltd. (JP) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014142298-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | 富山化学工業株式会社 (JP) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308103-A1 | NOVEL CRYSTALS OF HYDROXAMIC ACID DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION | HAAO, HACL2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | TSHR 3768/4885CYP3A4 765/4885HDAC8 168/4885 |
| US-20160039751-A1 | NOVEL HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | H1-0, H1-2, HDAC1 | TSHR 1820/4885CYP3A4 3086/4885HDAC8 30/4885 |
| US-20200062789-A1 | HYDROXAMIC ACID PRODRUG COMPOUND OR SALT THEREOF, LYOPHILIZED FORMULATION, LPXC INHIBITOR, AND ANTIBACTERIAL AGENT | LCT, LPXN, HDAC1 | TSHR 3092/4885CYP3A4 3984/4885HDAC8 52/4885 |
| US-20200308105-A1 | NOVEL METHOD FOR PRODUCING HYDROXAMIC ACID DERIVATIVE, AND INTERMEDIATE THEREFOR | HADH, HDAC11, HADHA | TSHR 3061/4885CYP3A4 1338/4885HDAC8 56/4885 |
| US-20190054179-A1 | NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF | HAAO, HPD, HCAR2 | TSHR 4400/4885CYP3A4 2793/4885HDAC8 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.